肿瘤切除术市场规模、份额、成长分析，按消融类型、按手术类型、按应用、按最终用户、按地区 - 行业预测，2025-2032

2023年全球肿瘤切除术市场规模估值为13.2亿美元，从2024年的15亿美元扩大到2032年的41.6亿美元，在预测期内（2025-2032年）预计复合年增长率为13.6%。

由于对更安全的替代疗法的需求不断增长以及癌症发病率的不断上升，治疗选择市场预计将大幅增长，特别是在高所得国家，预计该地区 80% 以上的人口将大幅增长。对微创和非侵入性治疗的日益偏好预计将进一步支持市场扩张。先进的肿瘤消融技术因其更快的恢復时间和更高的舒适度而受到外科医生和患者的青睐。与传统治疗相比，这些门诊病人技术降低了整体医疗成本。此外，切除手术正成为小肿瘤的首选选择，凸显了年度癌症筛检率对手术数量的间接影响。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析
• 技术分析
• 监管分析
• 专利分析
• 案例研究

肿瘤切除术市场规模：依消融类型划分

• 市场概况
• 射频消融术(RFA)
• 微波消融 (MWA)
• 雷射消熔
• 冷冻疗法
• 不可逆电穿孔 (IRE)
• 高强度聚焦超音波（HIFU）
• 其他的

肿瘤切除术市场规模：依手术类型

• 市场概况
• 微创消融
• 手术消融

肿瘤切除术市场规模：依应用分类

• 市场概况
• 肝癌
• 肺癌
• 肾癌
• 乳癌
• 摄护腺癌
• 骨癌
• 其他的

肿瘤切除术市场规模：依最终用户划分

• 市场概况
• 医院
• 癌症研究组织
• 专科诊所
• 日间手术中心 (ASC)

肿瘤切除术市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• Angiodynamics（Covidien）（US）
• Boston Scientific Corporation（US）
• Medtronic Plc（US）
• Ethicon, Inc.（US）
• Galil Medical Inc.（US）
• Misonix Inc.（US）
• HealthTronics（US）
• Mermaid Medical（Denmark）
• Theraclion（France）
• Chongqing Haifu Medical Technology Co., Ltd.（China）
• HS Hospital Service SPA（Italy）
• Hologic, Inc.（US）
• Varian Medical Systems（US）
• Cook Medical（US）
• LeVeen Medical（US）
• Integra LifeSciences（US）
• MedWaves, Inc.（US）
• Sanarus Technologies, Inc.（US）
• Bovie Medical Corporation（US）
• ThermoLife（US）

结论和建议

Global Oncology Ablation Market size was valued at USD 1.32 billion in 2023 and is poised to grow from USD 1.5 billion in 2024 to USD 4.16 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The market for therapeutic options is poised for significant growth driven by the escalating need for safer treatment alternatives and the increasing incidence of cancer, especially in low-income countries where cases are projected to surge by over 80%, compared to 41% in high-income regions. The growing inclination toward minimally invasive and non-invasive procedures is expected to further boost market expansion. Advanced tumor ablation techniques are gaining traction as both surgeons and patients favor these methods for their quick recovery times and enhanced comfort. Characterized as outpatient procedures, these techniques reduce overall healthcare costs compared to conventional treatments. Additionally, ablative surgery is becoming the preferred option for smaller tumors, highlighting the indirect influence of annual cancer screening rates on procedural volume.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Ablation Market Segmental Analysis

Global Oncology Ablation Market is segmented by Type of Ablation, Procedure Type, Application, End User and region. Based on Type of Ablation, the market is segmented into Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Laser Ablation, Cryoablation, Irreversible Electroporation (IRE), High-Intensity Focused Ultrasound (HIFU) and Others. Based on Procedure Type, the market is segmented into Minimally Invasive Ablation and Surgical Ablation. Based on Application, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Cancer and Others. Based on End User, the market is segmented into Hospitals, Cancer Research Institutes, Specialty Clinics and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Ablation Market

The global oncology ablation market is experiencing a significant boost in demand for advanced tumor ablation techniques, which is expected to persist throughout the forecast period. This surge is largely attributed to the growing preference among both surgeons and patients for minimally invasive procedures. The advantages associated with these techniques, such as reduced recovery times, enhanced patient comfort, and faster return to normal activities, are increasingly influencing decisions in favor of oncological interventions. As awareness and acceptance of these benefits continue to rise, the oncology ablation market is poised for substantial growth, reflecting a broader trend towards innovative and less invasive treatment options.

Restraints in the Global Oncology Ablation Market

The Global Oncology Ablation market faces several constraints primarily due to the complexities associated with ablation treatments. While tumor ablation therapy is gaining traction as a viable option for various solid organ cancers, the intricacies involved in the procedures can be daunting. Common complications such as blood loss and injuries to the target organ pose significant risks, categorized according to their associated threats. These adverse effects not only jeopardize patient safety but also increase the hesitance surrounding the adoption of these procedures, ultimately hindering market growth and limiting the wider acceptance of oncology ablation therapies in clinical settings.

Market Trends of the Global Oncology Ablation Market

The Global Oncology Ablation market is witnessing a significant shift as cooled radiofrequency probes gain traction among healthcare providers aiming for improved treatment methods. Market players are prioritizing technological advancements that enhance the precision, portability, and affordability of ablation techniques. Innovations such as High-Intensity Focused Ultrasound (HIFU), cryoablation, and image-guided equipment are at the forefront of this evolution. Notably, the advent of cooled radiofrequency denervation techniques is emerging as a critical contributor to market growth, facilitating complete denervation of the sacroiliac joint to effectively manage pain. This trend highlights a progressive move towards more efficient and impactful cancer treatment solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Oncology Ablation Market Size by Type of Ablation & CAGR (2025-2032)

• Market Overview
• Radiofrequency Ablation (RFA)
• Microwave Ablation (MWA)
• Laser Ablation
• Cryoablation
• Irreversible Electroporation (IRE)
• High-Intensity Focused Ultrasound (HIFU)
• Others

Global Oncology Ablation Market Size by Procedure Type & CAGR (2025-2032)

• Market Overview
• Minimally Invasive Ablation
• Surgical Ablation

Global Oncology Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Bone Cancer
• Others

Global Oncology Ablation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Cancer Research Institutes
• Specialty Clinics
• Ambulatory Surgical Centers (ASCs)

Global Oncology Ablation Market Size & CAGR (2025-2032)

• North America (Type of Ablation, Procedure Type, Application, End User)
  • US
  • Canada
• Europe (Type of Ablation, Procedure Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type of Ablation, Procedure Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type of Ablation, Procedure Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type of Ablation, Procedure Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Angiodynamics (Covidien) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ethicon, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Misonix Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthTronics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theraclion (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Haifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HS Hospital Service S.P.A (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeVeen Medical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedWaves, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanarus Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bovie Medical Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoLife (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations